Delivery Order SPE2DB20D2014-SPE2DB25FC46S
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a firm fixed price ceiling value of $10,933.96 and a performance period through May 27, 2025. The award is not set aside and is part of a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that enables Amerisourcebergen to supply a wide...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a ceiling value of $13,455.72 and a completion date of June 17, 2024. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The $1,692.25 fixed-price delivery order is placed by the Defense Logistics Agency (DLA), a defense agency, and has a performance period through June 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,560.25 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The award is not set-aside and was made under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,799.29, is for the delivery of a specific medical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of April 10, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,376.54 and an ultimate completion date of June 24, 2025. The contract is for the delivery of the pharmaceutical product BREYNA 160-4.5 MCG INHALER 10.3GM. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,977.56, is for the supply of a specific medical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the drug product BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,203.46 and a completion date of July 1, 2025. The award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.83 firm-fixed-price delivery order contract is for the supply of a BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,010.16 firm fixed-price delivery order covers the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a performance period through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC46SDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $70,121.63. It is a firm fixed-price delivery order contract with a period of performance through July 16, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.1k | 7/15/25 |